Skip to main content
. 2021 Feb 23;48(10):3315–3324. doi: 10.1007/s00259-021-05261-y

Fig. 2.

Fig. 2

Distribution of patients with clinically significant prostate cancer (sigPCa), clinically insignificant prostate cancer (insigPCa), and no evidence of disease on biopsy in correlation to PIRADS classification on multiparametric resonance magnetic imaging (a) and 68Ga-PSMA-11 PET/MRI result (b)